← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cancer Therapeutics Laboratories, Inc.
Los Angeles, CA
$3,419,016
Total funding
3
Grants
Funding over time
peak $2.5M · FY2005–12$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,419,016 · 3
By mechanism
N44$2,479,561 · 1
R41$639,999 · 1
N43$299,456 · 1
Investigators at Cancer Therapeutics Laboratories, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
OTHER FUNCTIONS SBIR PHASE II TOPIC 275, GENERIC ERBITUX FOR TREATMENT OF EGFR+$2,479,561
N44 · FY2012 · CA
Monoclonal Antibodies Against T-Regulatory Cells$320,000
R41 · FY2005 · CA
Monoclonal Antibodies Against T-Regulatory Cells$319,999
R41 · FY2004 · CA
TAS::75 0849::TAS THE MAIN TECHNICAL OBJECTIVE OF THIS CONTRACT IS TO GENERATE$299,456
N43 · FY2010 · CA